인공지능(AI) 기반 의약품 공급망 시장 보고서(2026년)

Artificial intelligence (AI) enabled pharma supply chain refers to the incorporation of AI technologies, including machine learning, predictive analytics, and automation, into pharmaceutical supply chain processes to enhance operational efficiency, accuracy, and responsiveness. It supports real-time decision-making across drug production, inventory control, distribution, and demand forecasting, ensuring the timely and cost-efficient delivery of pharmaceutical products.

The primary components of artificial intelligence (AI) enabled pharma supply chain include software, services, and platforms or artificial intelligence models. Software refers to AI-powered solutions that evaluate, automate, and optimize pharmaceutical supply chain operations to enhance efficiency, visibility, and decision-making. These solutions are deployed through cloud-based and on-premises models and are adopted by large enterprises and small and medium enterprises. The various applications include demand forecasting, inventory optimization, procurement and supplier risk management, warehouse automation, route optimization and logistics management, cold chain monitoring, predictive maintenance, real-time supply chain visibility, regulatory compliance and track and trace, and others and they are utilized by end users including pharmaceutical manufacturers, biotechnology companies, contract manufacturing organizations, pharmaceutical distributors, hospital and healthcare supply networks, third-party logistics providers, and others.

Tariffs are influencing the artificial intelligence (AI) enabled pharma supply chain market by increasing the cost of imported cloud infrastructure hardware, semiconductor-based computing systems, and specialized networking equipment used for digital supply chain operations. This is disrupting the deployment of AI-driven platforms across pharmaceutical manufacturers, biotechnology companies, and contract manufacturing organizations by slowing technology modernization and increasing operational expenditure. Hardware-intensive segments such as supply chain analytics infrastructure, IoT-enabled tracking systems, and automation-enabled logistics solutions are most affected due to their heavy reliance on global semiconductor and telecom supply chains. However, tariffs are also encouraging localized manufacturing of digital infrastructure, expansion of regional data centers, and diversification of technology sourcing, thereby strengthening long-term supply chain resilience and digital self-sufficiency across regions.

The artificial intelligence (AI) enabled pharma supply chain market size has grown rapidly in recent years. It will grow from $1.1 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to manual pharmaceutical supply chain operations, fragmented global drug distribution networks, limited adoption of digital tracking systems, paper-based inventory and procurement processes, reactive demand planning during healthcare crises.

The artificial intelligence (AI) enabled pharma supply chain market size is expected to see rapid growth in the next few years. It will grow to $2.23 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to rapid adoption of ai-driven predictive supply chain platforms, expansion of biologics and personalized medicine distribution, increasing regulatory compliance and traceability requirements, growth of cold chain logistics for temperature-sensitive drugs, rising integration of iot-enabled real-time tracking and monitoring systems. Major trends in the forecast period include decentralized pharmaceutical manufacturing and regional production expansion, surge in epidemic-driven demand volatility and preparedness planning, increasing complexity in biologics and temperature-sensitive drug logistics, stricter pharmaceutical quality assurance and compliance documentation requirements, growing dependence on specialized pharmaceutical third-party logistics and outsourcing networks.

The increasing adoption of personalized medicines is expected to propel the growth of the artificial intelligence (AI)-enabled pharma supply chain market going forward. Personalized medicine refers to a healthcare approach that tailors therapeutic interventions to individual patient profiles by utilizing genetic, biomarker, and clinical data to improve treatment precision and outcomes. The increasing adoption of personalized medicines is driven by advancements in genomics and molecular biology, which enable the precise identification of genetic and molecular differences among patients to tailor treatments for greater effectiveness and safety. Artificial intelligence (AI)-enabled pharma supply chains support personalized medicines by leveraging real-time data integration, predictive analytics, and precise demand and supply alignment to ensure the right therapy is manufactured, distributed, and delivered to individual patients in a timely and efficient manner. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, in 2023, the FDA approved 16 new personalized therapies for patients with rare diseases, representing a significant increase from the six approvals recorded in 2022. Therefore, the increasing adoption of personalized medicines is driving the growth of the artificial intelligence (AI)-enabled pharma supply chain market.

Leading companies operating in the artificial intelligence (AI) enabled pharma supply chain market are focusing on developing innovative solutions, such as predictive supply chain analytics, to anticipate demand fluctuations, optimize inventory levels, and enhance end-to-end visibility for improved efficiency and reduced operational risks. Predictive supply chain analytics is the use of artificial intelligence, machine learning, and historical plus real-time data to forecast future demand, disruptions, and inventory needs, enabling companies to make proactive and more efficient supply chain decisions. For example, in April 2024, Lonza Group AG, a Switzerland-based pharmaceutical manufacturing company, launched its AI-Enabled Route Scouting Service, an advanced digital solution designed to streamline synthetic route identification for novel APIs by combining Lonza's global chemical supply chain intelligence with artificial intelligence capabilities from Elsevier's Reaxys database. The service integrates extensive reaction datasets, process R&D expertise, and AI-driven recommendation engines to suggest optimized synthetic routes with improved efficiency and reduced development timelines, while also supporting sustainability by minimizing wasteful reaction screening. It is primarily used in early-stage drug development and process optimization for pharmaceutical manufacturing, helping companies reduce costs, improve scalability assessments, and accelerate time-to-market for new therapies.

In April 2024, Aptean Inc., a US-based software company, acquired Logility for $442.75 million. Through this acquisition, Aptean aims to strengthen its AI-driven supply chain planning capabilities and expand its cloud-based enterprise software portfolio by integrating Logility's advanced demand forecasting and supply chain optimization technologies to improve end-to-end decision intelligence for customers. Logility Supply Chain Solutions Inc. is a US-based provider of AI-enabled supply chain planning software, offering solutions for demand forecasting, inventory optimization, sales and operations planning (S&OP), and end-to-end supply chain visibility.

Major companies operating in the artificial intelligence (AI) enabled pharma supply chain market are Microsoft Corporation; Amazon Web Services Inc.; Google LLC; IBM Corporation; Oracle Corporation; SAP SE; Infor Inc.; Coupa Software Inc.; Blue Yonder Group Inc.; Palantir Technologies Inc.; SAS Institute Inc.; Manhattan Associates Inc.; Kinaxis Inc.; o9 Solutions Inc.; The Descartes Systems Group Inc.; Flexport Inc.; Logility Inc.; C3.ai Inc.; project44 Inc.; FourKites Inc.; Aera Technology Inc.; ToolsGroup S.r.l.; Shippeo SAS; ParkourSC Inc.; FarEye Technologies Pvt. Ltd.

North America was the largest region in the artificial intelligence (AI) enabled pharma supply chain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) enabled pharma supply chain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) enabled pharma supply chain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) enabled pharma supply chain market includes revenues earned by entities by providing services such as artificial intelligence-based demand forecasting, predictive maintenance, supplier risk management, and real-time pharmaceutical supply chain visibility services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The artificial intelligence (AI) enabled pharma supply chain market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) enabled pharma supply chain market statistics, including artificial intelligence (AI) enabled pharma supply chain industry global market size, regional shares, competitors with a artificial intelligence (AI) enabled pharma supply chain market share, detailed artificial intelligence (AI) enabled pharma supply chain market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) enabled pharma supply chain industry. This artificial intelligence (AI) enabled pharma supply chain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai) enabled pharma supply chain market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) enabled pharma supply chain ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) enabled pharma supply chain market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Software; Services; Platforms
• 2) By Deployment: Cloud Based; On Premises
• 3) By Enterprise Size: Large Enterprises; Small And Medium Enterprises
• 4) By Application: Demand Forecasting; Inventory Optimization; Procurement And Supplier Risk Management; Warehouse Automation; Route Optimization And Logistics Management; Cold Chain Monitoring; Predictive Maintenance; Real Time Supply Chain Visibility; Regulatory Compliance And Track And Trace; Other Applications
• 5) By End User: Pharmaceutical Manufacturers; Biotechnology Companies; Contract Manufacturing Organizations; Pharmaceutical Distributors; Hospital And Healthcare Supply Networks; Third Party Logistics Providers; Other End Users
• Subsegments:
• 1) By Software: Inventory Management Software; Demand Forecasting Software; Supply Chain Planning Software; Warehouse Management Software; Transportation Management Software; Predictive Analytics Software; Risk Monitoring Software; Quality Compliance Software; Procurement Management Software
• 2) By Services: Consulting Services; Implementation Services; Integration Services; Training And Support Services; Maintenance Services; Managed Services; Data Analytics Services; Cloud Deployment Services; Regulatory Compliance Services; System Optimization Services
• 3) By Platforms: Machine Learning Platforms; Predictive Analytics Platforms; Computer Vision Platforms; Natural Language Processing Platforms; Digital Twin Platforms; Decision Intelligence Platforms; Generative Artificial Intelligence Models; Prescriptive Analytics Platforms; Autonomous Supply Chain Platforms
• Companies Mentioned: Microsoft Corporation; Amazon Web Services Inc.; Google LLC; IBM Corporation; Oracle Corporation; SAP SE; Infor Inc.; Coupa Software Inc.; Blue Yonder Group Inc.; Palantir Technologies Inc.; SAS Institute Inc.; Manhattan Associates Inc.; Kinaxis Inc.; o9 Solutions Inc.; The Descartes Systems Group Inc.; Flexport Inc.; Logility Inc.; C3.ai Inc.; project44 Inc.; FourKites Inc.; Aera Technology Inc.; ToolsGroup S.r.l.; Shippeo SAS; ParkourSC Inc.; FarEye Technologies Pvt. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Autonomous Systems, Robotics & Smart Mobility
• 4.2. Major Trends
  • 4.2.1 Decentralized Pharmaceutical Manufacturing And Regional Production Expansion
  • 4.2.2 Surge In Epidemic-Driven Demand Volatility And Preparedness Planning
  • 4.2.3 Increasing Complexity In Biologics And Temperature-Sensitive Drug Logistics
  • 4.2.4 Stricter Pharmaceutical Quality Assurance And Compliance Documentation Requirements
  • 4.2.5 Growing Dependence On Specialized Pharmaceutical Third-Party Logistics And Outsourcing Networks

5. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Manufacturers
• 5.2 Biotechnology Companies
• 5.3 Contract Manufacturing Organizations
• 5.4 Pharmaceutical Distributors
• 5.5 Hospital And Healthcare Supply Networks

6. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Segmentation

• 9.1. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Software, Services, Platforms
• 9.2. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cloud Based, On Premises
• 9.3. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Large Enterprises, Small And Medium Enterprises
• 9.4. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Demand Forecasting, Inventory Optimization, Procurement And Supplier Risk Management, Warehouse Automation, Route Optimization And Logistics Management, Cold Chain Monitoring, Predictive Maintenance, Real Time Supply Chain Visibility, Regulatory Compliance And Track And Trace, Other Applications
• 9.5. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical Manufacturers, Biotechnology Companies, Contract Manufacturing Organizations, Pharmaceutical Distributors, Hospital And Healthcare Supply Networks, Third Party Logistics Providers, Other End Users
• 9.6. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inventory Management Software, Demand Forecasting Software, Supply Chain Planning Software, Warehouse Management Software, Transportation Management Software, Predictive Analytics Software, Risk Monitoring Software, Quality Compliance Software, Procurement Management Software
• 9.7. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Consulting Services, Implementation Services, Integration Services, Training And Support Services, Maintenance Services, Managed Services, Data Analytics Services, Cloud Deployment Services, Regulatory Compliance Services, System Optimization Services
• 9.8. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Machine Learning Platforms, Predictive Analytics Platforms, Computer Vision Platforms, Natural Language Processing Platforms, Digital Twin Platforms, Decision Intelligence Platforms, Generative Artificial Intelligence Models, Prescriptive Analytics Platforms, Autonomous Supply Chain Platforms

10. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Industry Metrics By Country

• 10.1. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
• 10.2. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Regional And Country Analysis

• 11.1. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 11.2. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 12.1. Asia-Pacific Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. Asia-Pacific Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 13.1. China Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 13.2. China Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 14.1. India Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 15.1. Japan Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 15.2. Japan Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 16.1. Australia Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 17.1. Indonesia Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 18.1. South Korea Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. South Korea Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 19.1. Taiwan Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. Taiwan Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 20.1. South East Asia Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. South East Asia Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 21.1. Western Europe Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 21.2. Western Europe Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 22.1. UK Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 23.1. Germany Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 24.1. France Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 25.1. Italy Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 26.1. Spain Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 27.1. Eastern Europe Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 27.2. Eastern Europe Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 28.1. Russia Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 29.1. North America Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. North America Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 30.1. USA Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. USA Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 31.1. Canada Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. Canada Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 32.1. South America Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 32.2. South America Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 33.1. Brazil Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 34.1. Middle East Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Middle East Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

• 35.1. Africa Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 35.2. Africa Artificial Intelligence (AI) Enabled Pharma Supply Chain Market, Segmentation By Component, Segmentation By Deployment, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Regulatory and Investment Landscape

37. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Competitive Landscape And Company Profiles

• 37.1. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Competitive Landscape And Market Share 2024
  • 37.1.1. Top 10 Companies (Ranked by revenue/share)
• 37.2. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market - Company Scoring Matrix
  • 37.2.1. Market Revenues
  • 37.2.2. Product Innovation Score
  • 37.2.3. Brand Recognition
• 37.3. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Company Profiles
  • 37.3.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.2. Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.3. Google LLC Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.4. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.5. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis

38. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Other Major And Innovative Companies

• SAP SE, Infor Inc., Coupa Software Inc., Blue Yonder Group Inc., Palantir Technologies Inc., SAS Institute Inc., Manhattan Associates Inc., Kinaxis Inc., o9 Solutions Inc., The Descartes Systems Group Inc., Flexport Inc., Logility Inc., C3.ai Inc., project44 Inc., FourKites Inc.

39. Global Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Competitive Benchmarking And Dashboard

40. Upcoming Startups in the Market

41. Key Mergers And Acquisitions In The Artificial Intelligence (AI) Enabled Pharma Supply Chain Market

42. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market High Potential Countries, Segments and Strategies

• 42.1. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market In 2030 - Countries Offering Most New Opportunities
• 42.2. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market In 2030 - Segments Offering Most New Opportunities
• 42.3. Artificial Intelligence (AI) Enabled Pharma Supply Chain Market In 2030 - Growth Strategies
  • 42.3.1. Market Trend Based Strategies
  • 42.3.2. Competitor Strategies

43. Appendix

• 43.1. Abbreviations
• 43.2. Currencies
• 43.3. Historic And Forecast Inflation Rates
• 43.4. Research Inquiries
• 43.5. The Business Research Company
• 43.6. Copyright And Disclaimer